Stroke Trial, Recruiting NCT06132399 Sponsor: Universidad de Almeria Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06132399
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People of any gender who have had either a stroke caused by a blocked blood vessel or a stroke caused by bleeding in the brain
  • The stroke must have occurred between 7 and 14 days before joining the trial
  • People who were living independently and managing daily life on their own before the stroke occurred
  • People who have some weakness in one or both arms, one or both legs, or both, but still retain a basic level of movement (based on a standard stroke assessment score)
  • People who are able to sit and stand with some control of their trunk (core body balance)
  • People who can understand simple instructions and are able to make their own decision about whether to sign a consent form

Who may not be able to join:

  • People with significant difficulty understanding or using language (aphasia) that would prevent them from following the required tasks
  • People with cognitive difficulties (problems with thinking or memory) that would prevent them from cooperating with tasks
  • People with serious behavioural problems or mental health conditions
  • People who have a blood clot in a leg vein, paralysis in all four limbs, a degenerative nerve or muscle disease, a broken bone in the leg, or a recent heart attack
  • People with failure of a major organ such as the heart, lungs, liver, or kidneys, or who have a malignant tumour or another serious unstable health condition
  • People with a history of previous stroke or other blood vessel disease affecting the brain, unless it has fully resolved
  • People who have a form of epilepsy triggered by flashing or flickering lights

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alberto Soriano-Maldonado, PhD, Universidad de Almeria

Phone: 950 01 55 50

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad de Almeria
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
1 August 2025

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Disability (The Barthel index)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov